Fascin expression in CD30-positive cutaneous lymphoproliferative disorders

Journal of Cutaneous Pathology

Volumn 29, Issue 5, 2002, Pages 295-300

  Kempf, Werner ^a,b   Levi, Edi ^a   Kamarashev, Jivko ^b   Kutzner, Heinz ^c   Pfeifer, Walther ^a   Petrogiannis Haliotis, Tina ^a   Burg, Günter ^b   Kadin, Marshall E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Dermatopathologische Gemeinschaftspraxis   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; CD30 ANTIGEN; FASCIN; PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; TUMOR MARKER;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPHOMATOID PAPULOSIS; LYMPHOPROLIFERATIVE DISEASE; MYCOSIS FUNGOIDES; PROTEIN EXPRESSION; REED STERNBERG CELL; SKIN TUMOR; T CELL LYMPHOMA; BIOSYNTHESIS; COMPARATIVE STUDY; HISTIOCYTIC LYMPHOMA; METABOLISM; SKIN DISEASE;

ANTIGENS, CD30; CARRIER PROTEINS; COMPARATIVE STUDY; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOMA, LARGE-CELL; LYMPHOMATOID PAPULOSIS; LYMPHOPROLIFERATIVE DISORDERS; MICROFILAMENT PROTEINS; MYCOSIS FUNGOIDES; SKIN DISEASES; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR MARKERS, BIOLOGICAL; HUMANS;

EID: 0036020485     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2002.290507.x     Document Type: Article

References (23)

1. EORTC classification for primary cutaneous lymphomas. A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer
2. Lymphomatoid papulosis and Ki-1 (CD30)-positive cutaneous large cell lymphomas
3. Atypical cells in lymphomatoid papulosis express the Hodgkin cell-associated antigen Ki-1
4. Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign-histologically malignant
5. Primary cutaneous CD30-positive large cell lymphoma. Definition of a new type of cutaneous lymphoma with a favorable prognosis. A European multicenter study of 47 patients
6. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment
7. Hodgkin's disease followed by lymphomatoid papulosis
8. The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas
9. Epidemiology of lymphomatoid papulosis
10. Lymphomatoid papulosis: A T-cell dyscrasia with a propensity to transform into malignant lymphoma
11. Hodgkin's disease, lymphomatoid papulosis, and cutanous T-cell lymphoma derived from a common T-cell clone
12. Lymphomatoid papulosis and associated cutaneous lymphoproliferative disorders exhibit a common clonal origin
13. The same dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis
14. Lymphomatoid papulosis in association with mycosis fungoides, a study of 15 cases
15. Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells
16. Fascin, a sensitive new marker for Reed-Sternberg cells of Hodgkin's disease
17. Epstein-Barr virus infection induces expression in B lymphocytes of a novel gene encoding an evolutionarily conserved 55-kilodalton actin-bundling protein
18. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)
19. Primary and secondary cutaneous CD30 (+) lymphoproliferative disorders: A report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment
20. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease
21. Absence of Epstein-Barr viral RNA in lymphomatoid papulosis
22. Absence of Epstein-Barr virus in lymphomatoid papulosis. An immunohistochemical and in situ hybridization study
23. Absence of anaplastic lymphoma kinase (ALK) and Epstein-Barr virus gene products in primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis